Filing Details
- Accession Number:
- 0001093557-21-000055
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-10 19:29:21
- Reporting Period:
- 2021-03-08
- Accepted Time:
- 2021-03-10 19:29:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1093557 | Dexcom Inc | DXCM | Surgical & Medical Instruments & Apparatus (3841) | 330857544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1286858 | R Kevin Sayer | 6340 Sequence Drive San Diego CA 92121 | Chairman, Ceo & President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-02-17 | 10,000 | $0.00 | 121,934 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2021-03-08 | 13,445 | $0.00 | 135,379 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2021-03-09 | 306 | $356.94 | 135,073 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-09 | 400 | $358.75 | 134,673 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-09 | 550 | $359.82 | 134,123 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-09 | 700 | $361.02 | 133,423 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-09 | 1,127 | $362.29 | 132,296 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-09 | 574 | $362.87 | 131,722 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-09 | 200 | $364.33 | 131,522 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The transaction represents a gift by the Reporting Person of 10,000 shares to a charitable donor advised fund.
- Included in this number are 56,792 unvested restricted stock units, 25,453 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 17,915 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 13,424 of which were granted on March 8, 2018 and shall vest through March 8, 2021.
- Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
- Included in this number are 42,356 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 11,943 of which were granted on March 8, 2019 and shall vest through March 8, 2022.
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 31, 2020, and amended effective December 16, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer.
- This transaction was executed in multiple trades at prices ranging from $358.40 to $359.35. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- This transaction was executed in multiple trades at prices ranging from $359.44 to $360.22. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- This transaction was executed in multiple trades at prices ranging from $360.44 to $361.43. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- This transaction was executed in multiple trades at prices ranging from $361.58 to $362.55. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- This transaction was executed in multiple trades at prices ranging from $362.58 to $363.51. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- This transaction was executed in multiple trades at prices ranging from $364.00 to $364.99. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Billionaire Hedge Funds
